 | Advance Micro-Draw FDA Cleared for Alternate Site Testing Advance Micro-draw Blood Glucose Monitoring System
Receives FDA Approval For Alternate Site Testing
Hypoguard USA, Inc. Offers People With Diabetes
More Choices To Finger TestingMarch 29, 2005 – Minneapolis, MN – Hypoguard, a leading U.S. manufacturer and marketer of blood glucose monitoring systems, today announced that it recently received clearance from the U.S. Food and Drug Administration (FDA) that will allow people using the Advance Micro-draw™ blood glucose system to use alternate site testing when checking their blood glucose level. Hypoguard is cleared to market alternate site testing capability for its most advanced blood glucose system, the Advance Micro-draw™ System. Now, Hypoguard willoffer patients the ability to draw a blood sample from their palm, in addition to traditional fingertip tests. This technique gives patients a less painful way to measure their blood glucose levels. “As a company dedicated to helping people manage diabetes, we can now provide more options and less pain for patients around the world. Our partners in home medical supplies, mail order, and retail can now offer customers this accurate system with an advanced feature set at an incredible value, ” said David Conn, President of Hypoguard USA Inc. People with diabetes typically monitor their blood glucose levels by obtaining a blood sample from their fingertips. Because the fingertip is highly concentrated with nerve endings, alternate site testing in the palm may be less painful. Hypoguard’s Advance Micro-draw™, featuring biosensor technology, requires only a small blood sample. Its small sample size results in less painful, more comfortable testing, aiding in testing compliance. The Advance Micro-draw™ is simple to use, requires just two simple steps, and achieves accurate test results in just 15 seconds. Its large display has easy-to-read digits for diabetes patients with visual impairment. The system also provides data management capabilities – including date and time, 250-test memory, and 14 and 30-day averaging. The Advance Micro-draw™ System is covered by Medicare and most private insurance plans. Hypoguard, USA Inc. www.hypoguard.com is the diagnostic division of Medisys PLC and specializes in design, development, manufacture and marketing of diagnostic products and related medical devices used to monitor chronic conditions such as diabetes. The company’s primary products include a broad line of blood glucose monitoring systems, safety lancets and lancing devices.
| |
